A modified regimen of FOLFIRINOX is shown to have impressive efficacy as adjuvant treatment compared with gemcitabine in pancreatic cancer. And the efficacy is seen despite its significant toxicity.
Medscape Medical News
Original Article: ‘Blown Away' With Adjuvant FOLFIRINOX in Pancreatic Cancer